Open AccessThe use of hydroxyurea pretreatment in chronic myeloid leukemia in the current tyrosine kinase inhibitor era
Author(s) -
Camille C B Kockerols,
Inge G.P. Geelen,
MarkDavid Levin,
Jeroen Janssen,
Avinash G. Dinmohamed,
Mels Hoogendoorn,
Jan J. Cornelissen,
Peter E. Westerweel
Publication year - 2022
Publication title -
haematologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.782
H-Index - 142
eISSN - 1592-8721
pISSN - 0390-6078
DOI - 10.3324/haematol.2021.280501
Subject(s) - myeloid leukemia , tyrosine kinase inhibitor , tyrosine kinase , cancer research , medicine , pharmacology , cancer , receptor
Not available.